Protocolli per patologia

Protocollo Tumore del sistema nervoso centrale

HIT-SIOP PNET 4 a prospective randomized controlled trial of hyperfractionated versus conventionally fractionated radiotherapy in standard risk medulloblastoma. (chiuso arruolamento ma ancora in uso in attesa nuovo protocollo)
Protocollo di diagnosi e cura del medulloblastoma metastatico e/o a istologia sfavorevole (HART)
2° protocollo AIEOP di diagnosi e cura degli ependimomi dell'età pediatrica
SIOP-LGG 2004 cooperative multicenter study for children and adolescents with low grade glioma
Protocol CLDE225C2301 Novartis: A Phase III, multi-center, open-label, randomized,controlled study of the efficacy and safety of oral LDE225 versus temozolomide in patients with Hh-pathway activated relapsed medulloblastoma.
Protocol for treatment of CNS high risk malignant tumors in patients aged < 3 years
BO25041 / ITCC-019 / HGG-01: An open-label, randomized, multi-centre comparative study of bevacizumab-based therapy in paediatric patients with newly diagnosed supratentorial high-grade glioma.
Studio epidemiologico "MOBI-KIDS - Rischio di tumori cerebrali ed esposizione a campi elettromagnetici a radiofrequenza nei bambini e negli adolescenti: uno studio multicentrico internazionale.
European Rhabdoid Registry - EU-RHAB.
SIOP CNS GCT II: prospective trial for the diagnosis and treatment of children, adolescents and young adults with Intracranial Germ Cell Tumours.

AIEOP EURO-LB 02 International protocol of the European Inter-group for Childhood Non-Hodgkin Lymphoma (EICNHL) for lymphoblastic lymphoma.(chiuso arruolamento ma ancora in uso in attesa nuovo protocollo)
AIEOP LNH 97 B protocollo multicentrico per la diagnosi e la terapia dei linfomi non Hodgkin (LNH) pediatrici B maturi (chiuso arruolamento ma ancora in uso in attesa nuovo protocollo)
AIEOP ALCL99 international protocol for diagnosis and treatment of anaplastic large cell lymphomas of childhood (chiuso arruolamento ma ancora in uso in attesa nuovo protocollo)
AIEOP ALCL-relapse, treatment protocol for relapsed anaplastic large cell lymphoma of childhood and adolescence
Intergroup trial for children or adolescents with B-Cell NHL or B-AL: Evaluation of rituximab efficacy and safety in high risk patients (Studio di Fase III)

AIEOP LH 2004
EuroNet-PHL-LP1: 1° Studio Internazionale per il Linfoma di Hodgkin, varietà prevalenza linfocitaria, nei bambini e negli adolescenti

Pagina 1 di 3